20102019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2018

PD-(L)1 Inhibition and Cardiac Damage: A Relevant Toxicity?

De Ruysscher, D., Dingemans, A-M., Vooijs, M. & Heymans, S., 1 Apr 2018, In : Journal of Thoracic Oncology. 13, 4, p. 478-479 2 p.

Research output: Contribution to journalEditorialAcademicpeer-review

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project

Kerr, K. M., Dafni, U., Schulze, K., Thunnissen, E., Bubendorf, L., Hager, H., Finn, S., Biernat, W., Vliegen, L., Losa, J. H., Marchetti, A., Cheney, R., Warth, A., Speel, E. -J., Blackhall, F., Monkhorst, K., Lewintre, E. J., Tischler, V., Clark, C., Bertran-Alamillo, J. & 23 others, Meldgaard, P., Gately, K., Wrona, A., Vandenberghe, P., Felip, E., De Luca, G., Savic, S., Muley, T., Smit, E. F., Dingemans, A. -M. C., Priest, L., Baas, P., Camps, C., Weder, W., Polydoropoulou, V., Geiger, T. R., Kammler, R., Sumiyoshi, T., Molina, M. A., Shames, D. S., Stahel, R. A., Peters, S. & Etop Lungscape Consortium, 1 Jan 2018, In : Annals of Oncology. 29, 1, p. 200-208 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

De Ruysscher, D., Wanders, R., Hendriks, L. E., van Baardwijk, A., Reymen, B., Houben, R., Bootsma, G., Pitz, C., van Eijsden, L. & Dingemans, A-M. C., Dec 2018, In : Journal of Thoracic Oncology. 13, 12, p. 1958-1961 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study

De Ruysscher, D., Dingemans, A-M. C., Praag, J., Belderbos, J., Tissing-Tan, C., Herder, J., Haitjema, T., Ubbels, F., Lagerwaard, F., El Sharouni, S. Y., Stigt, J. A., Smit, E., van Tinteren, H., van der Noort, V. & Groen, H. J. M., 10 Aug 2018, In : Journal of Clinical Oncology. 36, 23, p. 2366-2377 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer The AvaALL Randomized Clinical Trial

Gridelli, C., Carpeno, J., Dingemans, A-M. C., Griesinger, F., Grossi, F., Langer, C., Ohe, Y., Syrigos, K., Thatcher, N., Das-Gupta, A., Truman, M., Donica, M., Smoljanovic, V. & Bennouna, J., 1 Dec 2018, In : JAMA Oncology. 4, 12, 5 p., 183486.

Research output: Contribution to journalArticleAcademicpeer-review

Study Protocol of the NVALT25-ELDAPT Trial: Selecting the Optimal Treatment for Older Patients With Stage III Non-small-cell Lung Cancer

Driessen, E. J. M., Janssen-Heijnen, M. L. G., Maas, H. A., Dingemans, A-M. C. & van Loon, J. G. M., Nov 2018, In : Clinical Lung Cancer. 19, 6, p. E849-E852 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib

Vishwanathan, K., Dickinson, P. A., So, K., Thomas, K., Chen, Y-M., Carpeno, J., Dingemans, A-M. C., Kim, H. R., Kim, J-H., Krebs, M. G., Yang, J. C-H., Bui, B., Weilert, D. & Harvey, R. D., 1 Jun 2018, In : British Journal of Clinical Pharmacology. 84, 6, p. 1156-1169 14 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Training and Validating a Portable Electronic Nose for Lung Cancer Screening

van de Goor, R., van Hooren, M., Dingemans, A-M., Kremer, B. & Kross, K., 1 May 2018, In : Journal of Thoracic Oncology. 13, 5, p. 676-681 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancer

de Jong, E. E. C., Hendriks, L. E. L., van Elmpt, W., Gietema, H. A., Hofman, P. A. M., De Ruysscher, D. K. M. & Dingemans, A-M. C., 1 Sep 2018, In : Lung Cancer. 123, p. 112-115 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

2017

[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches

de Jong, E. E. C., van Elmpt, W., Leijenaar, R. T. H., Hoekstra, O. S., Groen, H. J. M., Smit, E. F., Boellaard, R., van der Noort, V., Troost, E. G. C., Lambin, P. & Dingemans, A-M. C., Jan 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, 1, p. 8-16 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

A combination of platelet features allows detection of early-stage cancer

Sabrkhany, S., Kuijpers, M. J. E., van Kuijk, S. M. J., Sanders, L., Pineda, S., Damink, S. W. M. O., Dingemans, A-M. C., Griffioen, A. W. & Egbrink, M. G. A. O., Jul 2017, In : European Journal of Cancer. 80, p. 5-13 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?

Derks, J. L., van Suylen, R. J., Thunnissen, E., den Bakker, M. A., Groen, H. J., Smit, E. F., Damhuis, R. A., van den Broek, E. C., Speel, E-J. M. & Dingemans, A-M. C., Jun 2017, In : European Respiratory Journal. 49, 6, 9 p., 1601838.

Research output: Contribution to journalArticleAcademicpeer-review

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer

van der Wekken, A. J., Pelgrim, R., 't Hart, N., Werner, N., Mastik, M. F., Hendriks, L., van der Heijden, E. H. F. M., Looijen-Salamon, M., de langen, A. J., Staal-van den Brekel, J., Riemersma, S., van den Borne, B. E., Speel, E. J. M., Dingemans, A-M. C., Hiltermann, T. J. N., van den Berg, A., Timens, W., Schuuring, E. & Groen, H. J. M., 1 Aug 2017, In : Clinical Cancer Research. 23, 15, p. 4251-4258 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non-small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria

Gandhi, L., Ou, S-H. I., Shaw, A. T., Barlesi, F., Dingemans, A-M. C., Kim, D-W., Camidge, D. R., Hughes, B. G. M., Yang, J. C. -H., de Castro, J., Crino, L., Lena, H., Do, P., Golding, S., Bordogna, W., Zeaiter, A., Kotb, A. & Gadgeel, S., Sep 2017, In : European Journal of Cancer. 82, p. 27-33 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Heat shock protein antagonists in early stage clinical trials for NSCLC

Hendriks, L. E. L. & Dingemans, A-M. C., May 2017, In : Expert Opinion on Investigational Drugs. 26, 5, p. 541-550 10 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Management of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studies

Meyer, M., Vliegenthart, R., Henzler, T., Buergy, D., Giordano, F. A., Kostrzewa, M., Rathmann, N., Brustugun, O. T., Crino, L., Dingemans, A-M. C., Dusmet, M., Fennell, D., Grunenwald, D., Huber, R. M., Moniuszko, M., Mornex, F., Papotti, M., Pilz, L., Senan, S., Syrigos, K. & 9 others, Perol, M., Gray, J. E., Schabel, C., van Meerbeeck, J. R., van Zandwijk, N., Zhou, C. C., Manegold, C., Voigt, W. & Roessner, E. D., Dec 2017, In : Journal of Thoracic Oncology. 12, 12, p. 1755-1765 11 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Management of stage I and II nonsmall cell lung cancer

McDonald, F., De Waele, M., Hendriks, L. E. L., Faivre-Finn, C., Dingemans, A-M. C. & Van Schil, P. E., Jan 2017, In : European Respiratory Journal. 49, 1, 16 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer

van Loon, J., Even, A. J. G., Aerts, H. J. W. L., Ollers, M., Hoebers, F., van Elmpt, W., Dubois, L., Dingemans, A-M. C., Lalisang, R. I., Kempers, P., Brans, B., Winnepenninckx, V., Speel, E-J., Thunnissen, E., Smits, K. M., Boellaard, R., Vugts, D. J., De Ruysscher, D. & Lambin, P., Feb 2017, In : Radiotherapy and Oncology. 122, 2, p. 267-273 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer

Yang, J. C-H., Ou, S-H. I., De Petris, L., Gadgeel, S., Gandhi, L., Kim, D-W., Barlesi, F., Govindan, R., Dingemans, A-M. C., Crino, L., Lena, N., Popat, S., Ahn, J. S., Dansin, E., Golding, S., Bordogna, W., Batas, B., Morcos, P. N., Zeaiter, A. & Shaw, A. T., Oct 2017, In : Journal of Thoracic Oncology. 12, 10, p. 1552-1560 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Quality assessment of positron emission tomography scans: recommendations for future multicentre trials

de Jong, E. E. C., van Elmpt, W., Hoekstra, O. S., Groen, H. J. M., Smit, E. F., Boellaard, R., Lambin, P. & Dingemans, A-M. C., 2017, In : Acta Oncologica. 56, 11, p. 1459-1464 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Screening for Brain Metastases in Resectable Non–Small Cell Lung Cancer

Hendriks, L. E., Hochstenbag, M. & Dingemans, A., 1 Mar 2017, In : Journal of Thoracic Oncology. 12, 3, p. e21-e21 1 p.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Open Access

The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC

Manegold, C., Dingemans, A-M. C., Gray, J. E., Nakagawa, K., Nicolson, M., Peters, S., Reck, M., Wu, Y-L., Brustugun, O. T., Crino, L., Felip, E., Fennell, D., Garrido, P., Huber, R. M., Marabelle, A., Moniuszko, M., Mornex, F., Novello, S., Papotti, M., Perol, M. & 7 others, Smit, E. F., Syrigos, K., van Meerbeeck, J. P., van Zandwijk, N., Yang, J. C-H., Zhou, C. & Vokes, E., Feb 2017, In : Journal of Thoracic Oncology. 12, 2, p. 194-207 14 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Why we should improve current practice of diagnosing and treating pulmonary large cell neuroendocrine carcinomas in patients with advanced disease

Derks, J., Van Suylen, R. J., Thunnissen, E., den Bakker, M., Groen, H., Smit, E., Damhuis, R., van den Broek, E., Speel, E-J. & Dingemans, A-M. C., 1 Oct 2017, In : European Respiratory Journal. 50, 4, 3 p., 1701658.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

2016

An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers

Derks, J., Speel, E. & Dingemans, A-M., Feb 2016, In : Journal of Thoracic Oncology. 11, 2, p. E25-E26 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Open Access
2 Citations (Scopus)

A Population-Based Analysis of Application of WHO Nomenclature in Pathology Reports of Pulmonary Neuroendocrine Tumors

Derks, J. L., van Suylen, R. J., Thunnissen, E., den Bakker, M. A., Smit, E. F., Groen, H. J. M., Speel, E. J. M. & Dingemans, A-M. C., Apr 2016, In : Journal of Thoracic Oncology. 11, 4, p. 593-602 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
1 Citation (Scopus)

A population based analysis of outcome of chemotherapy for metastatic pulmonary large cell neuroendocrine carcinomas: does the regimen matter?

Derks, J. L., van Suylen, R. J., Thunnissen, E., Den Bakker, M. A., Groen, H., Smit, E. F., Damhuis, R. A., Speel, E-J. & Dingemans, A-M. C., 1 Oct 2016, In : Annals of Oncology. 27

Research output: Contribution to journalConference Abstract/Poster in journalAcademic

Clinical features of large cell neuroendocrine carcinoma: a population-based overview

Derks, J. L., Hendriks, L. E., Buikhuisen, W. A., Groen, H. J. M., Thunnissen, E., van Suylen, R-J., Houben, R., Damhuis, R. A., Speel, E. J. M. & Dingemans, A-M. C., Feb 2016, In : European Respiratory Journal. 47, 2, p. 615-624

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?

Hendriks, L. E. L., Brouns, A. J. W. M., Amini, M., Uyterlinde, W., Wijsman, R., Bussink, J., Biesma, B., Oei, S. B., Stigt, J. A., Bootsma, G. P., Belderbos, J. S. A., De Ruysscher, D. K. M., Van den Heuvel, M. M. & Dingemans, A-M. C., Nov 2016, In : Lung Cancer. 101, p. 68-75

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group

Dietel, M., Bubendorf, L., Dingemans, A-M. C., Dooms, C., Elmberger, G., Calero Garcia, R., Kerr, K. M., Lim, E., Lopez-Rios, F., Thunnissen, E., Van Schil, P. E. & von Laffert, M., Feb 2016, In : Thorax. 71, 2, p. 177-184

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
5 Citations (Scopus)

Differentiating head and neck carcinoma from lung carcinoma with an electronic nose: a proof of concept study

van Hooren, M., Leunis, N., Brandsma, D. S., Dingemans, A-M. C., Kremer, B. & Kross, K. W., Nov 2016, In : European Archives of Oto-Rhino-Laryngology. 273, 11, p. 3897-3903

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
3 Citations (Scopus)

Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC

Sanders, K. J. C., Hendriks, L. E., Troost, E. G. C., Bootsma, G. P., Houben, R., Schols, A. M. W. J. & Dingemans, A-M. C., Jun 2016, In : Journal of Thoracic Oncology. 11, 6, p. 873-879

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
4 Citations (Scopus)

High heels, more costs

Dingemans, A-M., 2016, Maastricht: Universiteit Maastricht.

Research output: Book/ReportInaugural speechPopular

Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib

van den Boogaart, V., de Lussanet, Q. G., Houben, R., de Ruysscher, D., Groen, H. J. M., Marcus, J. T., Smit, E. F., Dingemans, A-M. C. & Backes, W. H., Mar 2016, In : Lung Cancer. 93, p. 20-27

Research output: Contribution to journalArticleAcademicpeer-review

Is selective nodal irradiation in non-small cell lung cancer still safe when using IMRT? Results of a prospective cohort study

Martinussen, H. M. A., Reymen, B., Wanders, R., Troost, E. G. C., Dingemans, A-M. C., Öllers, M., Houben, R., De Ruysscher, D., Lambin, P. & van Baardwijk - Renkens, A., Nov 2016, In : Radiotherapy and Oncology. 121, 2, p. 322-327

Research output: Contribution to journalArticleAcademicpeer-review

Medicamenteuze behandeling van kankercachexie

de Vos-Geelen, J. M. P. G. M., Sanders, K., Schols, A. & Dingemans, A-M., 2016, In : Nederlands Tijdschrift voor Oncologie. 13, 3, p. 72-80

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
9 Citations (Scopus)

Neuroendocrine Cancer of the Lung: A Diagnostic Puzzle

Derks, J., Speel, E., Thunnissen, E., van Suylen, R. J., Buikhuisen, W. A., van Velthuysen, M-L. & Dingemans, A-M., Mar 2016, In : Journal of Thoracic Oncology. 11, 3, p. e35-e38 7 p.

Research output: Contribution to journalEditorialAcademicpeer-review

Open Access
4 Citations (Scopus)

Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction

van Kruijsdijk, R. C. M., Visseren, F. L. J., Boni, L., Groen, H. J. M., Dingemans, A. M. C., Aerts, J. G. J. V., van der Graaf, Y., Ardizzoni, A. & Smit, E. F., Jul 2016, In : Annals of Oncology. 27, 7, p. 1280-1286

Research output: Contribution to journalArticleAcademicpeer-review

Proposals for the M-descriptors of the Eight TNM Classification for Non–Small Cell Lung Cancer: Are More Data Needed?

Hendriks, L., Dingemans, A-M. & de Ruysscher, D., Mar 2016, In : Journal of Thoracic Oncology. 11, 3, p. e42-e43 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Open Access

Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer

Nilsson, R. J. A., Karachaliou, N., Berenguer, J., Gimenez-Capitan, A., Schellen, P., Teixido, C., Tannous, J., Kuiper, J. L., Drees, E., Grabowska, M., van Keulen, M., Heideman, D. A. M., Thunnissen, E., Dingemans, A-M. C., Viteri, S., Tannous, B. A., Drozdowskyj, A., Rosell, R., Smit, E. F. & Wurdinger, T., 5 Jan 2016, In : Oncotarget. 7, 1, p. 1066-1075

Research output: Contribution to journalArticleAcademicpeer-review

Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: How to use E(B)US-NA information in addition to PET-CT for delineation?

Peeters, S. T., Dooms, C., van Baardwijk - Renkens, A., Dingemans, A-M. C., Martinussen, H., Vansteenkiste, J., Decaluwe, H., De Leyn, P., Yserbyt, J., Nackaerts, K., De Wever, W., Deroose, C. M. & De Ruysscher, D., Aug 2016, In : Radiotherapy and Oncology. 120, 2, p. 273-278

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice

Driessen, E. J. M., Bootsma, G. P., Hendriks, L. E. L., van den Berkmortel, F. W. P. J., Bogaarts, B. A. H. A., van Loon, J. G. M., Dingemans, A-M. C. & Janssen - Heijnen, M., Oct 2016, In : Radiotherapy and Oncology. 121, 1, p. 26-31

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)

The Optimal Local Treatment of Stage IIIA-N2 NSCLC: Is the Issue Finally Settled?

De Ruysscher, D., Vansteenkiste, J., Belderbos, J., Decaluwe, H. & Dingemans, A-M., Mar 2016, In : Journal of Thoracic Oncology. 11, 3, p. 284-286 3 p.

Research output: Contribution to journalEditorialAcademicpeer-review

Open Access
2 Citations (Scopus)

Updated efficacy and safety from the global phase II NP28673 study of alectinib in patients (pts) with previously treated ALK plus non-small-cell lung cancer (NSCLC)

Barlesi, F., Dingemans, A-M. C., Yang, J. C-H., Ou, S-H. I., Ahn, J. S., De Petris, L., Hughes, B., Lena, H., Bordogna, W., Golding, S., Morcos, P. N., Balas, B., Zeaiter, A. & Kim, D-W., 1 Oct 2016, In : Annals of Oncology. 27, supp. 6, 1 p., 1263P.

Research output: Contribution to journalConference Abstract/Poster in journalAcademic

2015

An Uncommon Presentation of Brain Metastases in a Lung Cancer Patient

Hendriks, L., Dingemans, A-M. C., Lammens, M., Anten, M. M., van den Heuvel, M. M. & Postma, L. A., Nov 2015, In : Journal of Thoracic Oncology. 10, 11, p. 1655-1656

Research output: Contribution to journalArticleAcademicpeer-review

A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)(aEuro)

Dingemans, A. -M. C., Groen, H. J. M., Herder, G. J. M., Stigt, J. A., Smit, E. F., Bahce, I., Burgers, J. A., van den Borne, B. E. E. M., Biesma, B., Vincent, A., van der Noort, V. & Aerts, J. G., Nov 2015, In : Annals of Oncology. 26, 11, p. 2286-2293

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)